Manmeet Soni is Summit Therapeutics’ Chief Operating Officer & Chief Financial Officer. Mr. Soni has extensive experience in transitioning biotechnology companies from development stage through commercialization and globalization. As Summit’s Chief Operating Officer, Mr. Soni will have responsibility for all commercial activities, finance, manufacturing, legal, information technology and human resources. Mr. Soni is also a member of Summit Therapeutics’ Board of Directors.

Mr. Soni joins Summit from Reata Pharmaceuticals, Inc., where he was President, Chief Operating Officer, and Chief Financial Officer. His tenure at Reata culminated in its sale to Biogen Inc. for $7.5 billion. Prior to joining Reata, Mr. Soni served as Senior Vice President and Chief Financial Officer of Alnylam Pharmaceuticals, Inc., a publicly held company, from May 2017 until August 2019. From March 2016 to February 2017, Mr. Soni served as the Executive Vice President, Chief Financial Officer, and Treasurer of ARIAD Pharmaceuticals, Inc., a publicly held biopharmaceutical company, when ARIAD was acquired by Takeda Pharmaceutical Company Limited.

Previously, Mr. Soni was the Chief Financial Officer at Pharmacyclics, Inc., which, along with the leadership of Mr. Duggan and Dr. Zanganeh, was sold to AbbVie Inc. for $21 billion in 2015. Prior to joining Pharmacyclics, Mr. Soni worked at ZELTIQ Aesthetics Inc., a publicly held medical technology company, as corporate controller. Prior to ZELTIQ, Mr. Soni worked at PricewaterhouseCoopers in their Life Science and Venture Capital Group. Mr. Soni has led an array of functions including finance, manufacturing, various strategic functions including ex-US commercial strategy and business development, as well as quality, risk, and program management, amongst others. Throughout his leadership career, Mr. Soni has raised over $7 billion through a variety of financing and business development deals.

Mr. Soni currently serves as a member of the board of directors of Pulse Biosciences, Inc. and previously served as a member of the board of directors of Arena Pharmaceuticals, Inc., each of which is a publicly traded company. Mr. Soni graduated from Hansraj College at Delhi University in India. He is a CPA and Chartered Accountant from the Institute of Chartered Accountants of India.